CardioGenics Inc - Product Pipeline Analysis, 2017 Update

  • ID: 4372848
  • Company Profile
  • 26 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • AMG Medical Inc
  • Biocore Systems Inc.
  • Somagen Diagnostics Inc
  • MORE
Summary

CardioGenics Inc (CardioGenics), a subsidiary of CardioGenics Holdings Inc is a medical device company that manufactures sensitive diagnostic test products to the in-vitro diagnostics market. The company provides products such as immunoassay tests, QL care analyzer, and paramagnetic beads. Its QL care analyzer is a portable and automated point of care immune analyzer. CardioGenics provides immunoassay tests such as plasminogen activator inhibitor type-1 test, heart failure genomics risk test, heart failure risk stratification test, and troponin I test. The company’s immunoassay tests are used to detect cardiac markers. It also develops a novel proprietary and patent-protected method to control the delivery of compounds to a chemical reaction automating the trigger. CardioGenics is headquartered in Mississauga, Ontario, Canada.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company CardioGenics Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • AMG Medical Inc
  • Biocore Systems Inc.
  • Somagen Diagnostics Inc
  • MORE
  • CardioGenics Inc Company Overview
  • CardioGenics Inc Company Snapshot
  • CardioGenics Inc Pipeline Products and Ongoing Clinical Trials Overview
  • CardioGenics Inc - Pipeline Analysis Overview
  • CardioGenics Inc - Key Facts
  • CardioGenics Inc - Major Products and Services
  • CardioGenics Inc Pipeline Products by Development Stage
  • CardioGenics Inc Pipeline Products Overview
  • Heart Failure Genomics Risk Test
  • Heart Failure Genomics Risk Test Product Overview
  • Heart Failure Risk Stratification Test
  • Heart Failure Risk Stratification Test Product Overview
  • Plasminogen Activator Inhibitor Type-1 Test
  • Plasminogen Activator Inhibitor Type-1 Test Product Overview
  • QL Care Analyzer
  • QL Care Analyzer Product Overview
  • Troponin-I Test
  • Troponin-I Test Product Overview
  • CardioGenics Inc - Key Competitors
  • CardioGenics Inc - Key Employees
  • CardioGenics Inc - Locations And Subsidiaries
  • Head Office
  • Recent Developments
  • CardioGenics Inc, Recent Developments
  • Aug 25, 2015: CardioGenics Enters Into Manufacturing Agreement With Ontario-Based Plasticap
  • Feb 17, 2015: USPTO Issues Notice of Allowance in Connection With CardioGenics' Self-Metering Cartridge Patent Application
  • Aug 21, 2013: CardioGenics Announces Commencement of Beta-Site Testing
  • Jun 05, 2013: CardioGenics Gets IRB Approval For Beta-Site Testing
  • Apr 03, 2012: CardioGenics Announces Agreements with INO to Manufacture QL Care Analyzers
  • Dec 20, 2011: CardioGenics Announces Submission to IRB for Beta Site Protocol Approval For QL Care Analyzer
  • Dec 20, 2011: CardioGenics Announces Submission to IRB for Beta Site Protocol Approval For Troponin-I cardiovascular test
  • Jun 29, 2011: CardioGenics Receives US Patent For QL Care Analyzer Core Technology
  • Feb 22, 2011: CardioGenics Receives Canadian Patent For QL Care Analyzer Core Technology
  • Feb 03, 2011: CardioGenics To File For 510(k) Clearance With FDA By Fourth Quarter Of 2011 For QL Care Analyzer
  • Appendix
  • Methodology
  • About
  • Contact
  • Disclaimer
List of Tables
  • CardioGenics Inc Pipeline Products and Ongoing Clinical Trials Overview
  • CardioGenics Inc Pipeline Products by Equipment Type
  • CardioGenics Inc Pipeline Products by Indication
  • CardioGenics Inc, Key Facts
  • CardioGenics Inc, Major Products and Services
  • CardioGenics Inc Number of Pipeline Products by Development Stage
  • CardioGenics Inc Pipeline Products Summary by Development Stage
  • Heart Failure Genomics Risk Test - Product Status
  • Heart Failure Genomics Risk Test - Product Description
  • Heart Failure Risk Stratification Test - Product Status
  • Heart Failure Risk Stratification Test - Product Description
  • Plasminogen Activator Inhibitor Type-1 Test - Product Status
  • Plasminogen Activator Inhibitor Type-1 Test - Product Description
  • QL Care Analyzer - Product Status
  • QL Care Analyzer - Product Description
  • Troponin-I Test - Product Status
  • Troponin-I Test - Product Description
  • CardioGenics Inc, Key Employees
  • Glossary
List of Figures
  • CardioGenics Inc Pipeline Products by Equipment Type
  • CardioGenics Inc Pipeline Products by Development Stage
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Somagen Diagnostics Inc
  • Biocore Systems Inc.
  • AMG Medical Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll